The German Biotechnology Sector 2016
-
<ic:message key='Bild vergrößern' />
- The German Biotechnology Sector 2016
More revenue, more jobs, more financing, more R&D expenditure – all the signs are pointing towards a sustainable growth. In addition, German companies are increasingly attracing the interest of international capital.
Employee development and new startups
With a total of ten start-ups (Q1/2014: 14) the founding dynamics in 2015 were at the same level as in previous years, at least from what can be seen now.
As shown in figure 6 on the left, there is an increase of total start-up numbers for the year and, from experience, an increase to more than 20 start-ups can also be expected for 2015. Most of the newcomers known today are active in the health area (8) and two in industrial biotech. Five insolvencies and five liquidations were reported in 2015.
Dynamic employment market
In terms of jobs, the German biotech sector is a dynamic employment market. In 2015, the 593 dedicated companies reported a total increase of more than 1,000 employees, with the largest increase in Baden-Württemberg (+240). Compared to previous years, in 2015 more middle-sized companies throughout the country employed more people.
